Pages that link to "Q61763072"

The following pages link to Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats (Q61763072):

Displaying 47 items.

• Redox mechanisms in hepatic chronic wound healing and fibrogenesis (Q24656684) (← links)
• Cirrhosis and autoimmune liver disease: Current understanding (Q28070154) (← links)
• PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer (Q28085644) (← links)
• Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition (Q33563882) (← links)
• Genetic and molecular abnormalities in cholangiocarcinogenesis (Q33570262) (← links)
• Regulators of Cholangiocyte Proliferation (Q33863341) (← links)
• Liver fibrosis (Q34005628) (← links)
• Principles of liver regeneration and growth homeostasis (Q34347580) (← links)
• Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis. (Q34439817) (← links)
• Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. (Q34597703) (← links)
• Involvement of cholangiocyte proliferation in biliary fibrosis (Q34992326) (← links)
• Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis (Q35064467) (← links)
• Fibrosis in autoimmune and cholestatic liver disease (Q35098677) (← links)
• Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms (Q35236464) (← links)
• Lipopolysaccharide enhances transforming growth factor β1-induced platelet-derived growth factor-B expression in bile duct epithelial cells (Q35683166) (← links)
• M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice. (Q36064546) (← links)
• The crucial role of cholangiocytes in cholangiopathies (Q36113261) (← links)
• Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease (Q36375200) (← links)
• Bile acid interactions with cholangiocytes (Q36506491) (← links)
• Inflammation and repair in viral hepatitis C. (Q36997773) (← links)
• Oxidative and nitrosative stress and fibrogenic response (Q37037061) (← links)
• Cholangiocyte proliferation and liver fibrosis. (Q37175438) (← links)
• Autocrine regulation of biliary pathology by activated cholangiocytes (Q37175512) (← links)
• Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks (Q37291238) (← links)
• Epithelial–mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death? (Q37841797) (← links)
• Epithelial-Mesenchymal Interactions in Biliary Diseases (Q37846143) (← links)
• Vascular biology of the biliary epithelium (Q38121567) (← links)
• Expression of Kit and platelet-derived growth factor receptors α and β in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571) (Q38450888) (← links)
• Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts (Q38544274) (← links)
• Starring role of toll-like receptor-4 activation in the gut-liver axis (Q38645789) (← links)
• Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis (Q38647835) (← links)
• The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice (Q38775284) (← links)
• The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis (Q38945443) (← links)
• Pathobiology of biliary epithelia. (Q39440062) (← links)
• Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion (Q40677743) (← links)
• PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury (Q42488577) (← links)
• Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development (Q42873669) (← links)
• Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis (Q42991520) (← links)
• Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus (Q43674589) (← links)
• Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices (Q46886393) (← links)
• Autocrine release of TGF-beta by portal fibroblasts regulates cell growth (Q47208152) (← links)
• Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development (Q47434172) (← links)
• Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. (Q54333861) (← links)
• Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation (Q61050018) (← links)
• Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress (Q73317711) (← links)
• Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations (Q80152309) (← links)
• The balancing act of the liver: tissue regeneration versus fibrosis (Q89769221) (← links)